• Primrose Bio provides pharmaceutical development and manufacturing technologies in therapeutic proteins (using Pfenex Expression Technology®) and nucleic acid-based drugs (via Prima RNApols™)
• Primrose Bio develops and markets high-performance enzymes (RNA Polymerases) for the production of mRNA vaccines & therapeutics
• Prima RNApols™ are available for evaluation under a simple MTA
• The company has established R&D collaborations and licenses with leaders in the mRNA-based drug segment

Dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines.